Cancer Research Cancer Health Disparities Conference 2009  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 4015-4022, November 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noguchi, T.
Right arrow Articles by Tanaka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noguchi, T.
Right arrow Articles by Tanaka, T.

A Factor Responsible for Increases in Ornithine Decarboxylase Activity in the Livers of Tumor-bearing Mice1

Tamio Noguchi2, Atsunori Kashiwagi and Takehiko Tanaka3

Department of Nutrition and Physiological Chemistry, Osaka University Medical School, 33 Joancho, Kitaku, Osaka 530, Japan

Ornithine decarboxylase activity in the livers, spleens, and kidneys of tumor-bearing mice changed markedly during tumor growth. These changes in enzyme activity were not due to infiltration or metastasis of tumor cells in these organs. After i.p. inoculation of Ehrlich tumor cells, enzyme activity in the liver and spleen increased remarkably, reaching a peak in 4 to 6 days and then quickly decreasing. Conversely, activity in the kidney, which was very high in normal mice, decreased markedly during tumor growth, nearly reaching zero on Day 6 and remaining very low until death.

Upon injection of a cell-free homogenate of Ehrlich tumor or cell-free ascites fluid, enzyme activity in the liver and spleen also increased markedly, but that in the kidney did not change. These increases in activity were not due to the effects of living tumor cells. Similar increases in enzyme activity were also observed in the livers of mice given injections of homogenates of Sarcoma 180 or Act. S tumor, or plasma from tumor-bearing mice, but not in the livers of mice given injections of homogenates of various nontumorous tissues, such as liver, kidney, spleen, muscle, regenerating liver, and fetus, or plasma obtained from normal mice. A similar increase in enzyme activity in the liver after injection of a cell-free preparation of tumor cells was observed in hypophysectomized and adrenalectomized mice; thus, these endocrine systems are probably not involved in the increase in enzyme activity in the livers of tumor-bearing mice.

Most of the factors responsible for increases in ornithine decarboxylase activity seemed to be tightly bound to intracellular components of tumor cells, probably in the nuclei. The factor was nondialyzable and heat-labile and was precipitated with ammonium sulfate, suggesting that it was a high-molecular-weight protein.

1 This study was supported by grants from the Ministry of Education and the Ministry of Health, Japan.

2 Present address: Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242.

3 To whom requests for reprints should be addressed.

Received 5/11/76. Accepted 8/ 3/76.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.